Biosensor- Attana Cell 200, label free, real time kinetics on cells

Attana AB introduces the Attana Cell 200 – the first system to permit real-time kinetic analysis of molecular interactions directly on cell surfaces, bringing drug development a step closer to the body.

As the first company in the world, Attana launches a system measuring molecular interactions label free directly on cell surfaces. In line with Attana’s innovative strategy, the Attana Cell 200 is a revolutionary system that rapidly generates biologically relevant information on molecular interactions with cell surfaces. Thanks to groundbreaking innovations and sedulous developments, Attana is the only player on the market that offers cells integrated as sensor surface. The experiments mimic real life conditions and generate information with higher biological relevance in comparison with traditional synthetic sensor surfaces.

Drug development is financially risky and time consuming. To save money and time the industry needs to early identify and eliminate unsuitable candidates. Attana Cell 200 biosensor system improves the selection process by rapidly identifying promising drug candidates. This enables early and well informed decisions in selecting relevant candidates while reducing unnecessary development costs and saving time. The Attana Cell 200 is label free, can run unpurified candidate molecules and has high throughput, resulting in fast and efficient screening of many drug candidates.

Attana Cell 200 is launched with new applications such as kinetic evaluation of cellular biomolecular interactions, e.g. antibody-receptor and lectin-carbohydrate, competition assays and cell capturing.

For more information, please contact Gabriela Suhoschi, Marketing Manager, Attana AB: gabriela.suhoschi@attana.com, +46 (0) 8- 674 57 12 or visit our web:www.attana.com

For press release in Swedish please see attached document.

About Attana AB

Based in Stockholm, Sweden, Attana AB develops and sells biosensors for analysis of biomolecular interactions. Our systems have since 2003 been employed at leading life science companies and universities worldwide, working in a wide variety of research fields. Attana’s biosensors can be used to determine specificity, kinetics and affinity, amongst other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.

Bifogade filer

PDF-dokument

Kategorisering

Ämnen:: Medicin,; Medicinsk forskning,; Vetenskap, teknik

Tags:: biosensor,; kinetics on cells,; cell,; attana cell 200,; attana,; qcm,; quartz crystal microbalance,; biosensors,; biotech,; lectin

Relaterade dokument

2012-03-06 09:00 Single-walled carbon have properties that make them useful for drug delivery, and their photo-thermal effects make them potentially useful in a wide range of applications, particularly the treatment of solid tumors. Follow link for full abstract: www.attana.com/pub_cells. See abstract on video (Attana Cell 200 data shown in min 04:55) http://www.dovepress.com/articles.php?article_id=9317

2011-04-13 08:58 Attana has several Quartz Crystal Microbalance (QCM) based instruments and applications, all catering to crucial needs and developed in close collaboration with industry and universities. Examples include kinetic analysis on cell surfaces, candidate selection screening, aggregation characterization, epitope mapping and concentration determination of biopharmaceuticals.

2010-06-23 08:46 The objective of this application note was to determine the binding properties of the lectin ConA towards human epidermoid carcinoma cells. Among other things it was found that a kinetic approach may be used to determine the apparent affinity and rate constants of lectin-cell glycan interactions, providing a greater understanding of the mechanism involved in the lectin recognition of cancer cells.

2010-06-16 09:42 The objective of this application note was to evaluate newly developed therapeutic antibodies in a biologically relevant context (cells) in order to detect failing candidates at an earlier stage. Among other things, it was found that real-time screening of drug candidates in a synthetic and in a cellular context together provides highly informative and biologically relevant data.

2010-06-09 08:34 The objective of this application note was to determine the glycosylation profile of cancer cells using a cell based QCM Biosensor assay. Among other things, it was found that a single surface can be used to perform lectin screening and to provide a highly relevant and reproducible determination of the glyco-profile of cancer cells.

2010-06-04 08:22 A list of publications where the Attana systems have been utilized. The publications relate to various species such as glycovesicles, antibodies, proteins, nanobodies and more.

2010-02-01 14:45 Attana AB lanserar Attana Cell 200 - ett banbrytande mätinstrument som tar läkemedelsutvecklingen ett steg närmare kroppen.

Se fler (7)

Kommentarer (0)

Lägg till kommentar

Presskontakt

Sök i pressrummet

Taggar

Prenumerera

Adress

Attana AB

Pressmeddelande